New England Journal of Medicine

Diseases, Conditions, Syndromes

Dexamethasone trial results confirm COVID-19 benefits but also risks

The keenly-awaited full results from a UK trial of the steroid dexamethasone were published Friday, confirming its life-saving benefits for COVID-19 patients on ventilators but suggesting it may cause harm if given too early.

Medications

Ticagrelor-aspirin beneficial for mild-to-moderate stroke, TIA

(HealthDay)—Ticagrelor-aspirin is associated with a reduced risk for the composite of stroke or death within 30 days of mild-to-moderate acute noncardioembolic ischemic stroke or transient ischemic attack (TIA), according ...

page 2 from 3